Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials.
Rahman-Filipiak A, Bolton C, Grill JD, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler NR, Rosen A, Lingler J, Wijsman E, Clark L; Advisory Group on Risk Evidence Education in Dementia (AGREED).
Rahman-Filipiak A, et al.
Alzheimers Dement. 2023 Sep;19(9):4270-4275. doi: 10.1002/alz.13380. Epub 2023 Jul 14.
Alzheimers Dement. 2023.
PMID: 37450489
Free PMC article.
Review.